Evidence map›Paper›PMID 41755724›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Nationwide outbreak of Shiga toxin-producing

Catarina Krug, Nathalie Jourdan-Da Silva, Mathieu Tourdjman, Patricia Mariani-Kurkdjian, Aurélie Cointe, Sophie Lefèvre, Sophie Bélichon, Claire Postic, Marie Françon, Hubert Herber and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Catarina KrugSanté publique France, Infectious Diseases Division, the French Public Health Agency, Saint-Maurice, France.
Nathalie Jourdan-Da SilvaSanté publique France, Infectious Diseases Division, the French Public Health Agency, Saint-Maurice, France.
Mathieu TourdjmanSanté publique France, Infectious Diseases Division, the French Public Health Agency, Saint-Maurice, France.
Patricia Mariani-KurkdjianNational associated Reference Centre for Escherichia coli, Department of Microbiology, Robert Debré Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Aurélie CointeNational associated Reference Centre for Escherichia coli, Department of Microbiology, Robert Debré Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
Sophie LefèvreInstitut Pasteur, Université Paris Cité, National Reference Centre for Escherichia coli, Shigella and Salmonella, Paris, France.
Sophie BélichonGeneral Directorate for Food (DGAL), Paris, France.
Claire PosticGeneral Directorate for Food (DGAL), Paris, France.
Marie FrançonDirectorate General for Competition Policy, Consumer Affairs and Fraud Control (DGCCRF), Paris, France.
Hubert HerberDirectorate General for Competition Policy, Consumer Affairs and Fraud Control (DGCCRF), Paris, France.
Delphine SergentetFrench National Reference Laboratory for Escherichia coli Including Shiga Toxin-Producing E. coli (NRL-STEC), VetAgro Sup-Campus Vétérinaire, Université de Lyon, Marcy-l'Étoile, France.
Sarah GanetFrench National Reference Laboratory for Escherichia coli Including Shiga Toxin-Producing E. coli (NRL-STEC), VetAgro Sup-Campus Vétérinaire, Université de Lyon, Marcy-l'Étoile, France.
Alicia Faure-BondatFrench National Reference Laboratory for Escherichia coli Including Shiga Toxin-Producing E. coli (NRL-STEC), VetAgro Sup-Campus Vétérinaire, Université de Lyon, Marcy-l'Étoile, France.
Marion DebinSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.
Charly Kengne-KuetcheSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, F75012, Paris, France.
Henriette de ValkSanté publique France, Infectious Diseases Division, the French Public Health Agency, Saint-Maurice, France.
Stéphane BonacorsiNational associated Reference Centre for Escherichia coli, Department of Microbiology, Robert Debré Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.
François-Xavier WeillInstitut Pasteur, Université Paris Cité, National Reference Centre for Escherichia coli, Shigella and Salmonella, Paris, France.
Gabrielle JonesSanté publique France, Infectious Diseases Division, the French Public Health Agency, Saint-Maurice, France.
Outbreak Investigation TeamThe members of the Outbreak Investigation Team are listed under Acknowledgements.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In February 2022, we observed an increase in the number of paediatric patients with haemolytic uraemic syndrome (HUS) associated with Shiga toxin-producing

Indexed as

Disease OutbreaksEscherichia coli InfectionsFlourFoodborne DiseasesFood MicrobiologyFrozen FoodsHemolytic-Uremic SyndromeShiga-Toxigenic Escherichia coliAdolescentCase-Control StudiesChildChild, PreschoolFemaleFranceHumansInfantChildrenDisease outbreaksFlourFood contaminationfrozen pizzasHaemolytic-uraemic syndromeShiga toxigenic Escherichia coli

Identifiers

PMID41755724
PMCPMC13074260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.